title: Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
abstract: Epstein-Barr virus (EBV)-positive B-cell lymphoproliferative disease develops in severe combined immunodeficient (SCID) mice inoculated with peripheral blood mononuclear cells (PBMC) from EBV(+) individuals (SCID/hu mice). In this study, we investigated the contribution of EBV reactivation and de novo infection of B lymphocytes to tumor outgrowth in SCID/hu mice. Evaluation of BZLF-1, an early EBV activation transcript, in cells recovered from the mouse peritoneal cavity within 16 days following PBMC transfer did not reveal EBV reactivation, while BZLF-1 expression was only detected in tumor masses or in vitro established lymphoblastoid cell lines. To confirm these data by a different strategy, we coinjected PBMC from seropositive donors with purified B cells from seronegative donors of different sex. Fluorescence in situ hydridization analysis of the resulting tumor masses disclosed that the overwhelming majority of lymphoma cells originated from the seropositive donor, implying that no substantial in vivo production and transmission of virus had occurred. Further, treatment of SCID/hu mice with ganciclovir did not prevent lymphoma development. Our results suggest that in the SCID/hu mouse, early EBV replication and secondary infection of bystander B cells does not occur, and that the direct outgrowth of the transformed B lymphocytes present within the PBMC inoculum is the predominant mechanism, which leads to lymphoma generation in this experimental model.
authors.affiliation: Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Piovan
authors.forename: L
authors.initials: L
authors.lastname: Bonaldi
authors.forename: S
authors.initials: S
authors.lastname: Indraccolo
authors.forename: V
authors.initials: V
authors.lastname: Tosello
authors.forename: C
authors.initials: C
authors.lastname: Menin
authors.forename: F
authors.initials: F
authors.lastname: Comacchio
authors.forename: L
authors.initials: L
authors.lastname: Chieco-Bianchi
authors.forename: A
authors.initials: A
authors.lastname: Amadori
mesh_terms: D000328:Adult; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology; D001402:B-Lymphocytes / Q000821:virology; D004268:DNA-Binding Proteins / Q000235:genetics; D005260:Female; D004854:Herpesvirus 4, Human / Q000502:physiology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000637:transplantation* / Q000821:virology; D008223:Lymphoma / Q000209:etiology* / Q000473:pathology / Q000821:virology; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D012333:RNA, Messenger / Q000032:analysis; D015534:Trans-Activators / Q000235:genetics; D014183:Transplantation, Heterologous; D014764:Viral Proteins; D014775:Virus Activation; D014779:Virus Replication / Q000502:physiology
chemical_list: D000998:Antiviral Agents; C063676:BZLF1 protein, Herpesvirus 4, Human; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D015534:Trans-Activators; D014764:Viral Proteins